Concepedia

Willis V. Burton

WV

11

Publications

628

Citations

11

H-Index

1982

Active since

Affiliations

Alexion Pharmaceuticals (United States)(Current)

Alexion Pharma (Switzerland)

Alexion Pharmaceuticals (France)

University of Connecticut

Yale University

Willis V. Burton is an author at Alexion Pharmaceuticals (United States) specializing in medicine, cell biology, and immunology.

Top concepts

Publications per year

1982–2003

11

Publications

11

Xenotransplantation of transgenic pig olfactory ensheathing cells promotes axonal regeneration in rat spinal cord

Toshio Imaizumi, Karen L. Lankford, Willis V. Burton et al. · Nature Biotechnology · 2000 · 180 citations · Full text

, , +11

Expression of the human α:1,2‐fucosyltransferase in transgenic pigs modifies the cell surface carbohydrate phenotype and confers resistance to human serum‐mediated cytolysis

Cristina Costa, Lisa Zhao, Willis V. Burton et al. · The FASEB Journal · 1999 · 89 citations · Full text

, , +27

The complement control protein homolog of herpesvirus saimiri regulates serum complement by inhibiting C3 convertase activity

William L. Fodor, Scott A. Rollins, Stella Bianco-Caron et al. · Journal of Virology · 1995 · 85 citations · Full text

, , +15

Transgenic pigs designed to express human CD59 and H‐transferase to avoid humoral xenograft rejection

Cristina Costa, Lisa Zhao, Willis V. Burton et al. · Xenotransplantation · 2002 · 60 citations

Extracellular matrix synthesis by skeletal muscle in culture. Proteins and effect of enzyme degradation.

Robert L. Beach, Willis V. Burton, W J Hendricks et al. · Journal of Biological Chemistry · 1982 · 48 citations · Full text

Rows per page

1–5 of 11